

1 dose contains:
Active substance:
Xylometazoline hydrochloride................... 140 mcg
Excipients:
Sorbitol..................................................... 1.96 mg
Hydrated castor oil................ 350 mcg
Levomenthol..................................................42 mcg
Zineol (Eucalyptol).................................... 28 mcg
Sodium Chloride.............................................. 728 mcg
Sodium hydrophosphate dihydrate................... 280 micrograms
Sodium dihydrogen phosphate dihydrate................ 280 mcg
Disodium edetat........................................... 70 mcg
Purified water............................................ up to 140 mcl
Transparent to slightly opaque, colorless to slightly colored, with menthol odor.
Decongestant vasoconstrictor (alpha adrenomimetic)
Xylometazoline belongs to the group of local vasoconstrictor agents (decongestants) with alpha-adrenomimetic action, causes constriction of the blood vessels of the nasal mucosa, thus eliminating the swelling and hyperemia of the nasal mucosa. Relieves nasal breathing in rhinitis. In therapeutic concentrations does not irritate the mucous, does not cause hyperemia. The action comes in a few minutes and lasts for 10 to 12 hours.
When applied topically, it is practically not absorbed, plasma concentrations are so small that they cannot be determined by modern analytical methods.
Acute respiratory diseases with rhinitis (runny nose), acute allergic rhinitis, pollinosis, sinusitis, eustachitis, otitis media (to reduce swelling of the nasopharyngeal mucosa). Preparing the patient for diagnostic manipulations in the nasal passages.
Hypersensitivity to the components of the drug, arterial hypertension, tachycardia, marked atherosclerosis, glaucoma, atrophic rhinitis, thyrotoxicosis, surgery on the meninges (in history), pregnancy, children up to 10 years of age.Carefully:
Diabetes mellitus, exertional angina III - IV functional class, prostatic hyperplasia. During lactation, the drug should be used only after a thorough assessment of the ratio of benefits and risks for mother and child, it is not allowed to exceed the recommended dosage.
Intranasal. For adults and children over 10 years old: 1 injection in each nasal passage (can be repeated if necessary); should not be applied more than 3 times a day. The duration of treatment is not more than 10 days.
Store at a temperature not higher than 30oC. Keep out of the reach of children.